| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.068 | 0.2 |